Results 201 to 210 of about 766,604 (355)

Abnormalities in subset distribution, activation, and differentiation of T ceils isolated from large intestine biopsies in HIV infection [PDF]

, 1994
Thomas Schneider, Reiner Ullrich, Clemens Bergs, Wolfgang Schmidt, E. O. Riecken, Martin Zeitz   +5 more
openalex   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Recent HIV Infections in Italy: Data from the HIV National Surveillance System, 2012-2023. [PDF]

Pathogens
Suligoi B, Regine V, Pugliese L, Galli C.   +3 more
europepmc   +1 more source

Behavioural surveillance and HIV prevention in men who have sex with men. Reports from Australia, Belgium, Canada, France, Germany, Switzerland, the United Kingdom, and the United States [PDF]

In 2006 the German Robert Koch Institute conducted the KABaSTI study, a national cross-sectional survey on knowledge, attitudes, and behaviour related to sexually transmitted infections among men who have sex with men (MSM) in Germany. Within the context
Velasco, Edward
core  

Changes in natural immunity during the course of HIV-1 infection [PDF]

, 1993
Bluma Brenner, Chryssa Gryllis, Mervyn Gornitsky, Mark A. Wainberg   +3 more
openalex   +1 more source

Extracellular Vesicle‐Based mRNA Therapeutics and Vaccines

Exploration, EarlyView.
This review provides a comprehensive analysis of recent advancements in extracellular vesicle (EV)‐based messenger RNA (mRNA) applications for therapeutics and vaccines. It systematically outlines strategies for mRNA encapsulation within EVs and elucidates the challenges associated with this technology, offering insights into future research directions
Qi Li, Haonan Xing, Abid Naeem, Kaiyue Zhang, Aiping Zheng, Yuanyu Huang, Mei Lu   +6 more
wiley   +1 more source

The Meandrous Route of Rilpivirine in the Search for the Miraculous Drug to Treat HIV Infections. [PDF]

Viruses
De Clercq E.
europepmc   +1 more source

HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression [PDF]

, 1994
Stephen J. Kent, Gianna Stent, Secondo Sonza, Stephen D. Hunter, Suzanne M. Crowe   +4 more
openalex   +1 more source

Exploring Plant‐Derived Nutraceuticals as Potential SARS CoV‐2 Mpro Inhibitors

Food Chemistry International, EarlyView.
The search for plant derived anti‐SARS‐CoV‐2 Mpro compounds starts from food plants and spices as rich sources of bioactive compounds. Both in silico screening and experimental validation are essential to assess their therapeutic potential, leading to candidates for drug development and dietary integration.
Shaza S. Issa, Tatiana V. Matveeva
wiley   +1 more source

Recent HIV infections and associated risk factors among newly diagnosed individuals in South Korea (2016-2023). [PDF]

Sci Rep
Wang JS, Kim EJ, Kim G, Kim S, Kim HM, Lee YJ, Hong HG, Kim MS, Jo NR, Heo TY, Kim K, Kim S, Yu J, Han MG.   +13 more
europepmc   +1 more source